Literature DB >> 10590210

Molecular epidemiology, pathogenesis and prevention of gastric cancer.

C T Stadtländer1, J W Waterbor.   

Abstract

Cancer of the stomach is one of the most commonly diagnosed malignancies and remains an important cause of mortality world wide. This type of cancer is not uniformly distributed among populations but shows a marked variation in both incidence and mortality. Although gastric cancer is declining in many parts of the world, the reasons for this decline are not well understood and its etiology remains unclear. Several factors are suspected to play a role in gastric carcinogenesis, including the effects of diet, exogenous chemicals, intragastric synthesis of carcinogens, genetic factors, infectious agents and pathological conditions in the stomach (such as gastritis). A new look at the results of epidemiological and experimental studies is important for the establishment of strategies for control. Since cancer of the stomach has a very poor prognosis in its more advanced stages, such a control program must have its main focus on primary prevention. This review describes our knowledge about cancer of the stomach regarding epidemiology, pathogenesis and prevention.

Entities:  

Mesh:

Year:  1999        PMID: 10590210     DOI: 10.1093/carcin/20.12.2195

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  54 in total

1.  Meta-analysis of the association of CYP1A1 polymorphisms with gastric cancer susceptibility and interaction with tobacco smoking.

Authors:  Fujun Han; Xinsheng Wang; Xuhui Wang; Yongfeng Luo; Wei Li
Journal:  Mol Biol Rep       Date:  2012-06-16       Impact factor: 2.316

2.  Expression of matrix metalloproteinases 2 and 9 in human gastric cancer and superficial gastritis.

Authors:  Clara Luz Sampieri; Sol de la Peña; Mariana Ochoa-Lara; Roberto Zenteno-Cuevas; Kenneth León-Córdoba
Journal:  World J Gastroenterol       Date:  2010-03-28       Impact factor: 5.742

3.  Microvessel density is a prognostic marker of human gastric cancer.

Authors:  Hong-Chuan Zhao; Rong Qin; Xiao-Xin Chen; Xia Sheng; Ji-Feng Wu; Dao-Bin Wang; Gui-Hua Chen
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

4.  Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma.

Authors:  Jae-Hyuk Lee; Susan C Abraham; Hyun-Soo Kim; Jong-Hee Nam; Chan Choi; Min-Cheol Lee; Chang-Soo Park; Sang-Woo Juhng; Asif Rashid; Stanley R Hamilton; Tsung-Teh Wu
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

5.  A novel genetic polymorphism of inducible nitric oxide synthase is associated with an increased risk of gastric cancer.

Authors:  Jing Shen; Run-Tian Wang; Li-Wei Wang; Yao-Chu Xu; Xin-Ru Wang
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

6.  Prognostic value of tripartite motif containing 29 expression in patients with gastric cancer following surgical resection.

Authors:  Chenghu Wang; Yi Zhou; Beibei Chen; Weiwei Yuan; Jinxi Huang
Journal:  Oncol Lett       Date:  2018-02-15       Impact factor: 2.967

7.  Eradication of Helicobacter Pylori Infections and GERD: A systematic review and meta-analysis.

Authors:  Wen-Ling Mou; Meng-Yao Feng; Li-Hua Hu
Journal:  Turk J Gastroenterol       Date:  2020-12       Impact factor: 1.852

8.  A p53 genetic polymorphism of gastric cancer: difference between early gastric cancer and advanced gastric cancer.

Authors:  Sun Young Yi; Woon Jung Lee
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

9.  Risk factors for the gastric cardia cancer: a case-control study in Fujian Province.

Authors:  Lin Cai; Zong-Li Zheng; Zuo-Feng Zhang
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

10.  Roles of Helicobacter pylori infection and cyclooxygenase-2 expression in gastric carcinogenesis.

Authors:  Wei-Hao Sun; Qian Yu; Hong Shen; Xi-Long Ou; Da-Zhong Cao; Ting Yu; Cheng Qian; Feng Zhu; Yun-Liang Sun; Xi-Ling Fu; Han Su
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.